UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Daily labile plasma iron as an indicator of chelator activity in Thalassaemia major patients

British journal of haematology, 2009-12, Vol.147 (5), p.744-751

2009

Volltextzugriff (PDF)

Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes

Diabetes care, 2004-11, Vol.27 (11), p.2730-2732

2004

Volltextzugriff (PDF)

Susceptibility of Endocrine, Cardiac, and Macrophage Cell Lines to Iron-Mediated Oxidative Damage and the Cytoprotective Effect of the Orally Active Chelator Deferasirox (Exjade®, ICL670)

Blood, 2007-11, Vol.110 (11), p.3825-3825

2007

Volltextzugriff (PDF)

Relocation of Cell Iron. A Mode of Chelation with Application to Diseases of Regional Iron Accumulation

Blood, 2007-11, Vol.110 (11), p.708-708

2007

Volltextzugriff (PDF)

Labile iron in cells and body fluids: physiology, pathology, and pharmacology

Frontiers in pharmacology, 2014-03, Vol.5, p.45

Cabantchik, Zvi Ioav

2014

Volltextzugriff (PDF)

The Labile Side of Iron Supplementation in CKD

Journal of the American Society of Nephrology, 2015-11, Vol.26 (11), p.2612-2619

2015

Volltextzugriff (PDF)

Iron and oxidative stress in cardiomyopathy in thalassemia

Free radical biology & medicine, 2015-11, Vol.88 (Pt A), p.3-9

2015

Volltextzugriff (PDF)

Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein

Proceedings of the National Academy of Sciences - PNAS, 2011-08, Vol.108 (32), p.13047-13052

2011

Volltextzugriff (PDF)

In Search for Symbolic Qualities of Iron: The Metal of Life

Frontiers in pharmacology, 2016-08, Vol.7, p.220-220

Cabantchik, Zvi Ioav

2016

Volltextzugriff (PDF)

GLP-1-RA Corrects Mitochondrial Labile Iron Accumulation and Improves β-Cell Function in Type 2 Wolfram Syndrome

The journal of clinical endocrinology and metabolism, 2016-10, Vol.101 (10), p.3592-3599

2016

Volltextzugriff (PDF)

Nutrient-deprivation autophagy factor-1 (NAF-1): biochemical properties of a novel cellular target for anti-diabetic drugs

PloS one, 2013-05, Vol.8 (5), p.e61202-e61202

2013

Volltextzugriff (PDF)

Characterization of Arabidopsis NEET Reveals an Ancient Role for NEET Proteins in Iron Metabolism

The Plant cell, 2012-05, Vol.24 (5), p.2139-2154

2012

Volltextzugriff (PDF)

Regional siderosis: a new challenge for iron chelation therapy

Frontiers in pharmacology, 2013-12, Vol.4, p.167

2013

Volltextzugriff (PDF)

ICL670A : a new synthetic oral chelator : Evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture

Blood, 2001-02, Vol.97 (4), p.1115-1122

2001

Volltextzugriff (PDF)

Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells

Blood, 2001-05, Vol.97 (9), p.2863-2871

2001

Volltextzugriff (PDF)

Iron Chelation For Diseases Of Regional Siderosis

Blood, 2013-11, Vol.122 (21), p.3435-3435

2013

Volltextzugriff (PDF)

A decisional algorithm to start iron chelation in patients with beta thalassemia

Haematologica (Roma), 2014-03, Vol.99 (3), p.e38-e40

2014

Volltextzugriff (PDF)

A Randomised 1 Year Study Evaluating the Impact of Vitamin C Supplementation on Systemic Iron Parameters of Iron Overload in Thalassemia Major Patients on Long-Term Treatment with Deferasirox

Blood, 2016-12, Vol.128 (22), p.1288-1288

2016

Volltextzugriff (PDF)

Evaluating Toxic Free Iron and Options for Keeping It At Bay in Iron Overloaded Patients

Blood, 2012-11, Vol.120 (21), p.2110-2110

2012

Volltextzugriff (PDF)

Increased Transferrin Concentration Ameliorates Anemia in Beta-Thalassemic Mice Through Changes in Iron Uptake and TfR1 Trafficking

Blood, 2011-11, Vol.118 (21), p.906-906

2011

Volltextzugriff (PDF)

The Molecular and Cellular Basis of Iron Toxicity in Iron Overload (IO) Disorders. Diagnostic and Therapeutic Approaches

Thalassemia reports, 2013-03, Vol.3 (11), p.e3

2013

Volltextzugriff (PDF)

Comparison of Overt and Cryptic Labile Plasma Iron In Thalassemia Patients In Israel and Gaza-Palestine

Blood, 2010-11, Vol.116 (21), p.5166-5166

2010

Volltextzugriff (PDF)

Cytoprotective Effect of ICL670 (Deferasirox) on At20 Endocrine Cells Susceptible to Iron-Evoked Oxidative Damage

Blood, 2006-11, Vol.108 (11), p.3825-3825

2006

Volltextzugriff (PDF)

Nutrient-Deprivation Autophagy Factor-1

PloS one, 2013-05, Vol.8 (5), p.e61202

2013

Volltextzugriff (PDF)

Apo-Transferrin Injections Reduce Transferrin Receptor 1 Concentration on Erythroid Precursors and Reverse Ineffective Erythropoiesis In Splenectomized Beta-Thalassemic Mice

Blood, 2010-11, Vol.116 (21), p.4283-4283

2010

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(27)
Dissertationen
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(13)
Humans
(9)
Iron
(7)
Hematology
(5)
Iron - Metabolism
(5)
Oxidative Stress
(5)
Biological And Medical Sciences
(4)
Fluorescence
(4)
Iron Chelating Agents - Therapeutic Use
(4)
Medical Sciences
(4)
Mitochondria
(4)
Animals
(3)
Diabetes
(3)
Endocrinology & Metabolism
(3)
Female
(3)
Hypoglycemic Agents - Pharmacology
(3)
Iron - Blood
(3)
Iron Overload
(3)
Iron Overload - Drug Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Daily labile plasma iron as an indicator of chelator activity in Thalassaemia major patients

Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes

Susceptibility of Endocrine, Cardiac, and Macrophage Cell Lines to Iron-Mediated Oxidative Damage and the Cytoprotective Effect of the Orally Active Chelator Deferasirox (Exjade®, ICL670)

Relocation of Cell Iron. A Mode of Chelation with Application to Diseases of Regional Iron Accumulation

Labile iron in cells and body fluids: physiology, pathology, and pharmacology

The Labile Side of Iron Supplementation in CKD

Iron and oxidative stress in cardiomyopathy in thalassemia

Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein

In Search for Symbolic Qualities of Iron: The Metal of Life

GLP-1-RA Corrects Mitochondrial Labile Iron Accumulation and Improves β-Cell Function in Type 2 Wolfram Syndrome

Nutrient-deprivation autophagy factor-1 (NAF-1): biochemical properties of a novel cellular target for anti-diabetic drugs

Characterization of Arabidopsis NEET Reveals an Ancient Role for NEET Proteins in Iron Metabolism

Regional siderosis: a new challenge for iron chelation therapy

ICL670A : a new synthetic oral chelator : Evaluation in hypertransfused rats with selective radioiron probes of hepatocellular and reticuloendothelial iron stores and in iron-loaded rat heart cells in culture

Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells

Iron Chelation For Diseases Of Regional Siderosis

A decisional algorithm to start iron chelation in patients with beta thalassemia

A Randomised 1 Year Study Evaluating the Impact of Vitamin C Supplementation on Systemic Iron Parameters of Iron Overload in Thalassemia Major Patients on Long-Term Treatment with Deferasirox

Evaluating Toxic Free Iron and Options for Keeping It At Bay in Iron Overloaded Patients

Increased Transferrin Concentration Ameliorates Anemia in Beta-Thalassemic Mice Through Changes in Iron Uptake and TfR1 Trafficking

The Molecular and Cellular Basis of Iron Toxicity in Iron Overload (IO) Disorders. Diagnostic and Therapeutic Approaches

Comparison of Overt and Cryptic Labile Plasma Iron In Thalassemia Patients In Israel and Gaza-Palestine

Cytoprotective Effect of ICL670 (Deferasirox) on At20 Endocrine Cells Susceptible to Iron-Evoked Oxidative Damage

Nutrient-Deprivation Autophagy Factor-1

Apo-Transferrin Injections Reduce Transferrin Receptor 1 Concentration on Erythroid Precursors and Reverse Ineffective Erythropoiesis In Splenectomized Beta-Thalassemic Mice

Suchergebnisse filtern